The Pharmaceutical Journal
Vol 278 No 7444 insert
24 March 2007

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Hay fever market

Retail pharmacy summary

The hay fever market has continued to blossom. The category grew from £75m in June 2005 to £87.6m by June 2006 (IRI consumer retail sales).

According to Capibus, this is as a result of new allergy sufferers — in 2006, 23 per cent of adults bought a hay fever treatment compared with 19 per cent in 2005. A spokeswoman from UCB Pharma, the Zirtek product licence holder, said growth is expected to continue, fuelled by increased consumer awareness and the development of pharmacy services.